X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immunology (13) 13
index medicus (11) 11
cancer (10) 10
melanoma (10) 10
humans (9) 9
oncology (9) 9
life sciences (7) 7
natural-killer-cells (7) 7
nk cells (7) 7
expression (6) 6
immunotherapy (6) 6
natural killer cells (6) 6
cytotoxicity (5) 5
dendritic cells (5) 5
female (5) 5
tumors (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
killer cells, natural - immunology (4) 4
lymphocytes (4) 4
male (4) 4
melanoma - immunology (4) 4
melanoma - pathology (4) 4
metastatic melanoma (4) 4
[sdv.can]life sciences [q-bio]/cancer (3) 3
adult (3) 3
aged (3) 3
animals (3) 3
cell activation (3) 3
cytokines (3) 3
flow cytometry (3) 3
immune system (3) 3
immunity (3) 3
killer cells, natural - metabolism (3) 3
lymphocytes t (3) 3
metastases (3) 3
middle aged (3) 3
multidisciplinary sciences (3) 3
nk cell lectin-like receptor subfamily k - immunology (3) 3
original research (3) 3
patients (3) 3
t-cells (3) 3
[sdv.imm]life sciences [q-bio]/immunology (2) 2
activation (2) 2
aged, 80 and over (2) 2
amlmds (2) 2
antibiotics (2) 2
antitumor activity (2) 2
braf inhibitor (2) 2
breast-cancer (2) 2
carcinoma (2) 2
cd4 antigens - immunology (2) 2
cell line, tumor (2) 2
cytometry (2) 2
cytotoxicity, immunologic - immunology (2) 2
dermatology (2) 2
gastrointestinal microbiome - immunology (2) 2
histocompatibility antigens class i - immunology (2) 2
immune checkpoint (2) 2
immune checkpoint inhibitors (2) 2
immunohistochemistry (2) 2
inhibition (2) 2
killer cells (2) 2
killer cells, natural - pathology (2) 2
macrophages (2) 2
malignant-melanoma (2) 2
medicine (2) 2
melanoma - blood (2) 2
melanoma - drug therapy (2) 2
melanoma - metabolism (2) 2
metastasis (2) 2
mice (2) 2
natural killer ligands (2) 2
neoplasm staging (2) 2
neoplasms (2) 2
neoplasms - therapy (2) 2
nk receptors (2) 2
nkg2d ligands (2) 2
pathology (2) 2
pd-1 protein (2) 2
pd-l1 protein (2) 2
peripheral-blood lymphocytes (2) 2
physiological aspects (2) 2
receptors (2) 2
recognition (2) 2
research article (2) 2
resistance (2) 2
rheumatoid-arthritis (2) 2
science (2) 2
signaling (2) 2
skin (2) 2
skin cancer (2) 2
t cell receptors (2) 2
t-cell (2) 2
tumor-infiltrating lymphocytes (2) 2
tumour immunosurveillance (2) 2
young adult (2) 2
[ sdv.imm.ii ] life sciences [q-bio]/immunology/innate immunity (1) 1
[ sdv.mhep.derm ] life sciences [q-bio]/human health and pathology/dermatology (1) 1
[sdv.imm.ii]life sciences [q-bio]/immunology/innate immunity (1) 1
[sdv.mhep.derm]life sciences [q-bio]/human health and pathology/dermatology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 91 - 97
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that... 
CELL LUNG-CANCER | MELANOMA | MICROENVIRONMENT | INTESTINAL MICROBIOTA | CYCLOPHOSPHAMIDE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | GENES | RESISTANCE | ANTITUMOR IMMUNITY | NIVOLUMAB | CD4 Antigens - immunology | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gastrointestinal Microbiome - genetics | Fecal Microbiota Transplantation | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Metagenome - genetics | Neoplasms - therapy | Animals | Receptors, CCR - immunology | Interleukin-12 - immunology | Receptors, CXCR3 - immunology | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Verrucomicrobia - genetics | Verrucomicrobia - immunology | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Epithelial tumors | Physiological aspects | Health aspects | Methods | Apoptosis | PD-1 protein | Interleukin | Microbiomes | Transplantation | Lymphocytes T | Anticancer properties | Microbiota | Lymphocytes | Bacteria | Feces | Supplementation | Gnotobiotics | Kidneys | Melanoma | Dietary supplements | Interleukin 12 | Abundance | CXCR3 protein | Patients | CD4 antigen | Immune checkpoint | Antibiotics | Lungs | Flora | PD-L1 protein | Relative abundance | Antitumor activity | CCR9 protein | Tumors | Kidney transplantation | Cancer | Life Sciences
Journal Article
Nature Immunology, ISSN 1529-2908, 08/2017, Volume 18, Issue 9, pp. 1004 - 1015
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 06/2017, Volume 8
Natural killer (NK) cells are potent antitumor effectors, involved in hematological malignancies and solid tumor immunosurveillance. They infiltrate various... 
BRAF inhibitor | melanoma | tumour immunosurveillance | immune checkpoint inhibitors | AMLMDS | natural killer ligands
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, p. e76928
Melanomas are aggressive skin tumors characterized by high metastatic potential. Immunotherapy is a valuable alternative for metastatic melanoma patients... 
TUMOR-INFILTRATING LYMPHOCYTES | METASTATIC MELANOMA | DENDRITIC CELLS | RECOGNITION | LIGANDS | MULTIDISCIPLINARY SCIENCES | ENVIRONMENT | RECEPTOR NKP46/NCR1 | EXPRESSION | CARCINOMA | NK RECEPTORS | Immunohistochemistry | Melanoma - blood | Coculture Techniques | Humans | Middle Aged | NK Cell Lectin-Like Receptor Subfamily K - immunology | Male | Skin Neoplasms - blood | Young Adult | Lymphocyte Activation - immunology | Flow Cytometry | Interleukin-2 - immunology | NK Cell Lectin-Like Receptor Subfamily K - metabolism | Aged, 80 and over | Killer Cells, Natural - immunology | Adult | Female | Natural Cytotoxicity Triggering Receptor 1 - immunology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Cells, Cultured | Immunophenotyping | Melanoma - pathology | Cell Degranulation - immunology | Lymphocyte Activation - drug effects | Melanoma - immunology | K562 Cells | Cell Line, Tumor | Interleukin-2 - pharmacology | Natural Cytotoxicity Triggering Receptor 1 - metabolism | Aged | Killer Cells, Natural - metabolism | Cytotoxicity, Immunologic - immunology | Neoplasm Staging | Medical research | Chemotherapy | Killer cells | Immunotherapy | Melanoma | Medicine, Experimental | Metastasis | Cancer | Skin cancer | Toxicity | Cytotoxicity | Blood | Metastases | Defects | NKG2 antigen | Receptors | Interleukin 2 | Consent | Natural killer cells | Immune system | Immunoglobulins | Dendritic cells | Dermatology | T cell receptors | Patients | Studies | Pathology | Degranulation | Ligands | Skin | Tumors | Life Sciences | Human health and pathology | Innate immunity | Immunology
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 03/2019, Volume 10, p. 661
The antitumor functions of NK cells are regulated by the integration of positive and negative signals triggered by numerous membrane receptors present on the... 
NKG2D CARs | NATURAL-KILLER-CELLS | I-RELATED CHAIN | IMATINIB DISCONTINUATION | SURFACE EXPRESSION | IMMUNOLOGY | CHRONIC MYELOID-LEUKEMIA | natural killer cells | NKG2D | NK CELLS | NKG2D ligands | PERIPHERAL-BLOOD LYMPHOCYTES | tumor immunosurveillance | UP-REGULATION | NKG2D LIGAND EXPRESSION | T-CELLS
Journal Article
Journal Article
Medecine/Sciences, ISSN 0767-0974, 08/2018, Volume 34, Issue 8-9, pp. 657 - 659
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133363
Journal Article
OncoImmunology, ISSN 2162-402X, 04/2019, Volume 8, Issue 4, p. e1568812
Background: The gut microbiota has been shown to be an important determinant of the efficacy of immune checkpoint inhibitions (ICI) in cancer. Several lines of... 
immune check-point inhibition | gut microbiome | antibiotics | Melanoma | immunotherapy | dysbiosis | ONCOLOGY | MICROBIOME | IMMUNOLOGY | CANCER | IPILIMUMAB
Journal Article